Manulife (Manufacturers Life Insurance)’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14M Buy
133,823
+110,972
+486% +$11.6M 0.01% 712
2025
Q1
$2.67M Buy
22,851
+534
+2% +$62.3K ﹤0.01% 1387
2024
Q4
$1.89M Sell
22,317
-306
-1% -$25.9K ﹤0.01% 1592
2024
Q3
$2.03M Sell
22,623
-278
-1% -$25K ﹤0.01% 1541
2024
Q2
$1.84M Buy
22,901
+999
+5% +$80.4K ﹤0.01% 1525
2024
Q1
$1.75M Sell
21,902
-8,390
-28% -$670K ﹤0.01% 1565
2023
Q4
$2.41M Buy
30,292
+9,940
+49% +$791K ﹤0.01% 1413
2023
Q3
$1.42M Buy
20,352
+6,878
+51% +$481K ﹤0.01% 1552
2023
Q2
$968K Buy
13,474
+451
+3% +$32.4K ﹤0.01% 1678
2023
Q1
$803K Buy
13,023
+35
+0.3% +$2.16K ﹤0.01% 1733
2022
Q4
$1M Buy
12,988
+1,157
+10% +$89.2K ﹤0.01% 1605
2022
Q3
$528K Buy
11,831
+40
+0.3% +$1.79K ﹤0.01% 1945
2022
Q2
$452K Buy
11,791
+157
+1% +$6.01K ﹤0.01% 2119
2022
Q1
$482K Sell
11,634
-2,865
-20% -$119K ﹤0.01% 2230
2021
Q4
$548 Sell
14,499
-414
-3% -$16 ﹤0.01% 2203
2021
Q3
$492K Sell
14,913
-950
-6% -$31.3K ﹤0.01% 2299
2021
Q2
$1.07M Buy
15,863
+25
+0.2% +$1.69K ﹤0.01% 1954
2021
Q1
$897K Sell
15,838
-899
-5% -$50.9K ﹤0.01% 1955
2020
Q4
$1.36M Buy
16,737
+603
+4% +$49.1K ﹤0.01% 1674
2020
Q3
$1.15M Sell
16,134
-470
-3% -$33.5K ﹤0.01% 1601
2020
Q2
$1.27M Sell
16,604
-417
-2% -$31.8K ﹤0.01% 1532
2020
Q1
$1M Buy
17,021
+1,704
+11% +$100K ﹤0.01% 1516
2019
Q4
$1.58M Sell
15,317
-179
-1% -$18.5K ﹤0.01% 1484
2019
Q3
$342K Buy
15,496
+834
+6% +$18.4K ﹤0.01% 2242
2019
Q2
$378K Buy
+14,662
New +$378K ﹤0.01% 2216
2017
Q3
Sell
-492
Closed -$3K 4241
2017
Q2
$3K Sell
492
-41
-8% -$250 ﹤0.01% 4031
2017
Q1
$2K Hold
533
﹤0.01% 3929
2016
Q4
$4K Hold
533
﹤0.01% 3965
2016
Q3
$4K Hold
533
﹤0.01% 3912
2016
Q2
$4K Hold
533
﹤0.01% 3850
2016
Q1
$5K Buy
+533
New +$5K ﹤0.01% 3774